Public markets often show benefits of association in the cannabis industry — particularly when the sector crosses paths with a market one might expect — which seems to be the case after a new partnership was unveiled between a specialty coffee manufacturer and an operator of marijuana care centers in Canada.

On Thursday (April 12) National Access Cannabis (TSXV:NAC) revealed a strategic association with The Second Cup (TSX:SCU), a retailer of specialty coffee that operates franchise cafes of its brand, to create an entirely new network of recreational cannabis dispensaries in Western Canada.


The two companies announced there could be an expansion of these new dispensaries to additional provinces in Canada as the laws advance regarding the sale of cannabis.

National Access Cannabis indicated it plans to apply for licenses to dispense cannabis products and — if the company obtains said licenses — will “leverage Second Cup’s extensive Canadian retail footprint to construct retail stores carrying leading cannabis products.”

Shares of both companies make significant gains

This new partnership proved to entice the investor market as both companies enjoyed a high volume of trading and a significant increase in share prices.

Second Cup’s gamble to enter the cannabis space with this deal has proven worthwhile based on early returns. After the markets closed on Thursday shares of SCU increased 28.73 amounting to a C$0.79 gain per share for investors.

At one point of trading, Second Cup’s shares reached C$3.74, its highest price per share of the year so far. The previous close for the company was C$2.75.

National Access Cannabis enjoyed a more moderate growth to its stock based on Thursday’s announcement. The company’s shares on the TSX Venture exchange increased 9.89 percent in value.

By the times the open markets closed National Access Cannabis’ shares were valued at C$1.

Second Cup’s real estate appears to have played a key part in the decision to execute this new partnership, according to Mark Goliger, CEO of National Access Cannabis.

This relationship allows us to quickly expand our footprint in proven high-traffic retail locations across Canada,” Goliger said.

As part of the agreement, National Access Cannabis issued a set of warrants to Second Cup for the option to purchase 5,000,000 of its own common shares. The company said these warrants hold an exercise price of C$0.91 per common share and will last until the year 2023.

“This strategic relationship provides Second Cup with a great opportunity to leverage our select real estate assets to increase value for shareholders and franchisee partners,” Garry Macdonald, Second Cup’s President, and CEO.

National Access Cannabis’ busy year so far

The company made a splash in the industry on February when it obtained one of the four coveted retail licenses in the province of Manitoba and has become a key option for a variety of cannabis partners, including CannaRoyalty (CSE:CRZ,OTCQX:CNNRF), Cannabis Wheaton (TSXV:CBW) and private marijuana producer Tilray.

Winning these licenses means National Access Cannabis will be allowed to build, develop and operate cannabis stores in approved municipalities. However, the number of locations the company is allowed to construct will be evaluated with the province.

In March CannaRoyalty revealed deals in place to bring its brands and products to Canada if the regulations ever allow it to be. CannaRoyalty plans to bring those products to the National Access Cannabis stores, as permitted by the laws.

CannaRoyalty acts as an operator focused on the US cannabis market and therefore has not obtained a licensed producer (LP) or applied itself for a license. Afzal Hasan, executive vice president for corporate development with CannaRoyalty, told INN this deal is meant as a preemptive measure.

“[CannaRoyalty’s] deep experience successfully supplying branded cannabis products to the Californian marketplace will serve us well as we look to grow our retail footprint outside of Manitoba, to Alberta, British Columbia and beyond,” Goliger said in a statement.

Hasan previously told INN that CannaRoyalty wanted to secure distribution channels before announcing any introduction of their products to the Canadian market, given the fact he’s unsure if it will ever be allowed for them to do so.

Investor takeaway

National Access Cannabis has been able to pique the interest of the market with significant deals on paper. The key for them will be to capitalize on these partnerships if they are allowed to develop.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less